미국의 부인과 기기 시장 : 규모, 동향(2023-2029년) : MedSuite

In 2022, the gynecological devices market in the United States reached a value of approximately $1.3 billion, driven by nearly 3 million gynecological procedures performed annually. Our extensive research in the medical device market encompassed over 70 gynecological device companies across the United States. Through our comprehensive methodology, we analyzed market sizes, unit sales, company market shares, and developed accurate forecasts.

The complete report suite on the U.S. market for gynecological devices covers a wide range of products, including assisted reproduction technology devices, global endometrial ablation, uterine fibroid embolization devices, gynecological endoscopes, gynecological resection electrodes, morcellators, pelvic floor electrical stimulation devices, fluid management devices, pelvic organ prolapse repair devices, and hysterosalpingography (HSG) catheters.

DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Gynecological Procedure Volumes
• Forecasts Until 2029, and Historical Data to 2019
• Market Drivers & Limiters for Each Gynecological Device market
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

U.S. GYNECOLOGICAL DEVICES MARKET INSIGHTS

As companies vie for market share, pricing strategies in the gynecological devices industry become crucial. This has led to a downward trend in average selling prices (ASPs) across market segments. Lower prices may entice purchasers to explore alternative solutions, prompting providers of alternative gynecological devices to further reduce their prices in a cross-category price competition. The formation of purchasing groups by clinics has bolstered buyers' leverage, compelling sellers to offer competitive prices to secure broader market access. The competitive landscape puts pressure on sellers to ensure their pricing aligns with buyer expectations and demands.

One significant trend in the U.S. market for gynecological devices is the avoidance, when possible, of hysterectomies as a treatment option. Fibroids and endometriosis affect a significant proportion of women in the United States, with 20-25% of reproductive-age women and 11% of women between 15 and 44 being affected, according to the U.S. National Institutes of Health (NIH). To address these conditions, physicians are increasingly turning to minimally invasive treatments such as hysteroscopic surgeries, uterine artery embolization, and endometrial ablation, when the condition permits. These alternative procedures offer less invasiveness, shorter recovery periods, and have become preferred options for patients seeking to avoid the need for hysterectomy.

U.S. GYNECOLOGICAL DEVICES MARKET SHARE INSIGHTS

Hologic, Medtronic, Cooper Surgical, and Minerva Surgical emerged as the dominant players in the U.S. gynecological device market, collectively capturing more than 50% of the total market share.

Hologic dominated the U.S. gynecological device market with its strong presence in various segments, including global endometrial ablation, hysteroscopic morcellators, endoscopes, and fluid management devices.

Medtronic secured the second position, competing in the morcellator and fluid management device markets. Their TruClear™ Hysteroscopic morcellator contributed significantly to their market share in the morcellator device segment.

Minerva Surgical held the fourth position, participating in the global endometrial ablation, gynecological endoscope, morcellator, and fluid management markets. Their acquisition of the intrauterine portfolio from Boston Scientific in 2020 further strengthened their position.

Cooper Surgical emerged as the leading competitor in the assisted reproduction technology device, gynecological endoscope, and HSG catheter segments, contributing to their third-leading market share in the U.S. gynecological device market.

SEGMENTS COVERED:

• Assisted reproduction technology devices
• Global endometrial ablation
• Uterine fibroid embolization devices
• Gynecological endoscopes
• Gynecological resection electrodes
• Morcellator devices
• Pelvic floor electrical stimulation devices
• Fluid management devices
• Pelvic organ prolapse repair devices
• Hysterosalpingography (HSG) catheters

TABLE OF CONTENT

• Table of Contents
• List of Figures
• List of Charts

Executive summary

• U.S. Gynecological Device Market Overview
• Competitive Analysis
• Market Trends
• Market Developments
• Procedure Numbers
• Procedure Codes Investigated
• Markets Included
• Key Report Updates
• Version History

Research methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

Impact of covid-19 on the U.S. Gynecological device Market

• 2.1. Introduction
• 2.2. Analysis By Market Segment
  • 2.2.1. Best Case Scenario
  • 2.2.2. Base Case Scenario
  • 2.2.3. Worst Case Scenario

Disease Overview

• 3.1. Basic Anatomy
• 3.2. Disease Treatment and Diagnostic
  • 3.2.1. Introduction
  • 3.2.2. General Diagnostics
  • 3.2.3. Assisted Reproduction Technologies (ART)
    • 3.2.3.1. ART Costs
  • 3.2.4. Abnormal Uterine Bleeding
  • 3.2.5. Gynecologic Cancer and Tumors in Reproductive System
  • 3.2.6. Female Sterilization
  • 3.2.7. Urinary Incontinence
  • 3.2.8. Pelvic Organ Prolapse
• 3.3. Patient Demographics
  • 3.3.1. Assisted Reproduction Technologies (ART)
  • 3.3.2. Abnormal Uterine Bleeding
  • 3.3.3. Gynecologic Cancer and Tumors in Reproductive System
  • 3.3.4. Pelvic Organ Prolapse
  • 3.3.5. Endometriosis
  • 3.3.6. Polycystic ovary syndrome
  • 3.3.7. Female Sterilization

Product Assessment

• 4.1. Introduction
• 4.2. Product Portfolios
  • 4.2.1. Assisted Reproduction Technology Device
  • 4.2.2. Global Endometrial Ablation Market
  • 4.2.3. Uterine Fibroid Embolization Device
  • 4.2.4. Gynecological Endoscopes
  • 4.2.5. Gynecological Resection Electrode
  • 4.2.6. Gynecological Morcellators
  • 4.2.7. Pelvic Floor Electrical Stimulation Device
  • 4.2.8. Fluid Management Device
  • 4.2.9. Pelvic Organ Prolapse Repair Device
  • 4.2.10. HSG Catheter
  • 4.2.11. Uterine Manipulators
• 4.3. Regulatory Issues and Recalls
  • 4.3.1. Assisted Reproduction Technology Device Market
  • 4.3.2. Gynecological Endoscope Market
  • 4.3.3. Gynecological Resection Electrode Market
  • 4.3.4. Morcellator Market
  • 4.3.5. Fluid Management Device Market
  • 4.3.6. Pelvic Organ Prolapse Repair Device Market
  • 4.3.7. HSG Catheter Market
  • 4.3.8. Uterine Manipulator Market
• 4.4. Clinical Trials
  • 4.4.1. Assisted Reproduction Technology Device
  • 4.4.2. Global Endometrial Ablation
  • 4.4.3. Uterine Fibroid Embolization Device
  • 4.4.4. Gynecological Endoscopes
  • 4.4.5. Gynecological Morcellators
  • 4.4.6. Pelvic Floor Electrical Stimulation Device
  • 4.4.7. Pelvic Organ Prolapse Repair Device
  • 4.4.8. Uterine Manipulators

U.S. Gynecological Device Market Overview

• 5.1. Introduction
• 5.2. Market Overview and Trend Analysis
• 5.3. Drivers and Limiters
  • 5.3.1. Market Drivers
  • 5.3.2. Market Limiters
• 5.4. Competitive Market Share Analysis
• 5.5. Mergers and Acquisitions
• 5.6. Company Profiles
  • 5.6.1. Boston Scientific
  • 5.6.2. Coloplast
  • 5.6.3. Cooper Surgical
  • 5.6.4. Hologic
  • 5.6.5. Laborie Medical
  • 5.6.6. Medtronic
  • 5.6.7. Merit Medical Systems
  • 5.6.8. Minerva Surgical
  • 5.6.9. Olympus
  • 5.6.10. Richard Wolf
• 5.7. SWOT Analysis
  • 5.7.1. Boston Scientific
  • 5.7.2. Coloplast
  • 5.7.3. Cooper Surgical
  • 5.7.4. Hologic
  • 5.7.5. Laborie Medical
  • 5.7.6. Medtronic
  • 5.7.7. Merit Medical Systems
  • 5.7.8. Minerva Surgical
  • 5.7.9. Olympus
  • 5.7.10. Richard Wolf

Procedure Numbers

• 6.1. Introduction
  • 6.1.1. Ovarian Cancer Incidence
  • 6.1.2. Pelvic Screens
• 6.2. Procedures Number Overview
  • 6.2.1. Fallopian Tube Procedures
  • 6.2.2. Assisted Reproduction Technology Procedures by Type
  • 6.2.3. Cervical Repair and Biopsy Procedures
  • 6.2.4. Global Endometrial Ablation Procedures
    • 6.2.4.1. Thermal Ablation Procedures
    • 6.2.4.2. Hydrothermal Ablation Procedures
    • 6.2.4.3. Radiofrequency Ablation Procedures
    • 6.2.4.4. Cryoablation Procedures
  • 6.2.5. Uterine Fibroid Embolization Procedures by Type
  • 6.2.6. Gynecological Endoscope Procedures
  • 6.2.7. Morcellation Procedures
  • 6.2.8. Vaginal Procedures
  • 6.2.9. Pelvic Organ Prolapse Procedures by Type
  • 6.2.10. HSG Catheter Procedures by Type
  • 6.2.11. Myomectomy Procedures
  • 6.2.12. Hysterectomy Procedures
    • 6.2.12.1. Hysterectomy Procedures by Type
    • 6.2.12.1. Hysterectomy Procedures by Approach

Assisted Reproduction Technology Device Market

• 7.1. Introduction
  • 7.1.1. Media
  • 7.1.2. Vitrification
• 7.2. Market Overview
• 7.3. Market Analysis and Forecast
  • 7.3.1. Oocyte Retrieval Needle Market
  • 7.3.2. Micropipette Market
    • 7.3.2.1. Flexible Pipette Market
    • 7.3.2.2. ICSI Pipette Market
  • 7.3.3. Embryo Transfer Catheter Market
  • 7.3.4. Reproduction Media Market
    • 7.3.4.1. Culture Media Market
    • 7.3.4.2. Sperm Preparation Media Market
    • 7.3.4.3. Manipulation Media Market
    • 7.3.4.4. Freeze/Thaw Media Market
• 7.4. Drivers and Limiters
  • 7.4.1. Market Drivers
  • 7.4.2. Market Limiters
• 7.5. Competitive Market Share Analysis

Global Endometrial Ablation Market

• 8.1. Introduction
  • 8.1.1. Hydrothermal Ablation
  • 8.1.2. Radiofrequency Ablation
  • 8.1.3. Cryoablation
  • 8.1.4. Roller-Ball Ablation
• 8.2. Market Overview
• 8.3. Market Analysis and Forecast
  • 8.3.1. Total Global Endometrial Ablation Market
  • 8.3.2. Thermal Ablation Device Market
  • 8.3.3. Hydrothermal Ablation Device Market
  • 8.3.4. Radiofrequency Ablation Device Market
  • 8.3.5. Cryoablation Device Market
• 8.4. Drivers and Limiters
  • 8.4.1. Market Drivers
  • 8.4.2. Market Limiters
• 8.5. Competitive Market Share Analysis

Uterine Fibroid Embolization Device Market

• 9.1. Introduction
  • 9.1.1. Microspheres
  • 9.1.2. Polyvinyl Alcohol Particles
  • 9.1.3. Drug-Eluting Particles
• 9.2. Market Overview
• 9.3. Market Analysis and Forecast
  • 9.3.1. Microsphere Market
  • 9.3.2. PVA Particle Market
• 9.4. Drivers and Limiters
  • 9.4.1. Market Drivers
  • 9.4.2. Market Limiters
• 9.5. Competitive Market Share Analysis

Gynecological Endoscope Market

• 10.1. Introduction
  • 10.1.1. Hysteroscopes
  • 10.1.2. Colposcopes
  • 10.1.3. Resectoscopes
• 10.2. Market Overview
• 10.3. Market Analysis and Forecast
  • 10.3.1. Hysteroscope Market
    • 10.3.1.1. Reusable Hysteroscope Market
    • 10.3.1.2. Reusable Rigid Hysteroscope Market
    • 10.3.1.3. Reusable Flexible Hysteroscope Market
    • 10.3.1.3.1. Video Flexible Hysteroscope Market
    • 10.3.1.3.2. Fiber Flexible Hysteroscope Market
    • 10.3.1.4. Disposable Hysteroscope Market
  • 10.3.2. Colposcope Market
    • 10.3.2.1. Video Colposcope Market
    • 10.3.2.2. Non-Video Colposcope Market
  • 10.3.3. Resectoscope Market
• 10.4. Drivers and Limiters
  • 10.4.1. Market Drivers
  • 10.4.2. Market Limiters
• 10.5. Competitive Market Share Analysis

Gynecological Resection Electrode Market

• 11.1. Introduction
• 11.2. Market Overview
• 11.3. Market Analysis and Forecast
  • 11.3.1. Monopolar Loop Electrode Market
  • 11.3.2. Bipolar Loop Electrode Market
• 11.4. Drivers and Limiters
  • 11.4.1. Market Drivers
  • 11.4.2. Market Limiters
• 11.5. Competitive Market Share Analysis

Morcellator Market

• 12.1. Introduction
• 12.2. Market Analysis and Forecast
  • 12.2.1. Laparoscopic Morcellator Market
  • 12.2.2. Hysteroscopic Morcellator Market
• 12.3. Drivers and Limiters
  • 12.3.1. Market Drivers
  • 12.3.2. Market Limiters
• 12.4. Competitive Market Share Analysis

Pelvic Floor Electrical Stimulation Device Market

• 13.1. Introduction
• 13.2. Market Overview
• 13.3. Market Analysis and Forecast
  • 13.3.1. Home-Based PFES Device Market
  • 13.3.2. Office-Based PFES Device Market
• 13.4. Drivers and Limiters
  • 13.4.1. Market Drivers
  • 13.4.2. Market Limiters
• 13.5. Competitive Market Share Analysis

Fluid Management Device MarkeT

• 14.1. Introduction
• 14.2. Market Overview
• 14.3. Market Analysis and Forecast
  • 14.3.1. Fluid Management Equipment Market
  • 14.3.2. Fluid Management Tubing Market
• 14.4. Drivers and Limiters
  • 14.4.1. Market Drivers
  • 14.4.2. Market Limiters
• 14.5. Competitive Market Share Analysis

Pelvic Organ Prolapse Repair Device Market

• 15.1. Introduction
• 15.2. Market Overview
• 15.3. Market Analysis and Forecast
  • 15.3.1. Transvaginal Mesh Market
  • 15.3.2. Sacrocolpopexy Mesh Market
• 15.4. Drivers and Limiters
  • 15.4.1. Market Drivers
  • 15.4.2. Market Limiters
• 15.5. Competitive Market Share Analysis

HSG Catheter Market

• 16.1. Introduction
• 16.2. Market Analysis and Forecast
• 16.3. Drivers and Limiters
  • 16.3.1. Market Drivers
  • 16.3.2. Market Limiters
• 16.4. Competitive Market Share Analysis

Appendix: Uterine Manipulator market

• 17.1. Introduction
• 17.2. Market Analysis and Forecast
• 17.3. Drivers and Limiters
  • 17.3.1. Market Drivers
  • 17.3.2. Market Limiters
• 17.4. Competitive Market Share Analysis

Abbreviations